Histopathological evidence of osilodrostat-induced regression of a cortisol-producing adrenocortical adenoma
JCEM Case Reports · 29.04.2026 · 4 (6)
DOI: 10.1210/jcemcr/luag093 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 18.05.2026. Verfasst von Maki Kanzawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Kobe University Hospital, Kobe, Hyogo 650-0017, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Health, Labour and Welfare Policy Research.
Abstract (Originalsprache)
We describe histopathological and ultrastructural evidence of osilodrostat-induced regression of a cortisol- and possibly aldosterone-producing adrenocortical adenoma. An 82-year-old woman with adrenal Cushing syndrome received preoperative osilodrostat therapy. Seventy days after starting osilodrostat, the patient developed an adrenal crisis, and the adrenal tumor obviously decreased in size. Laparoscopic adrenalectomy was performed 11 months after osilodrostat plus hydrocortisone treatment. Histological examination revealed no evident hemorrhage, necrosis, or conspicuous apoptosis. Instead, diffuse and extensive infiltration of CD163-positive histiocytes was observed, outnumbering the tumor cells. Residual neoplastic cells exhibited a global reduction in the expression of cortisol-synthesizing enzymes. Notably, focal weak CYP11B2 (aldosterone synthase) positivity was detected in the tumor, whereas adjacent nontumorous cortex showed preserved rather prominent CYP11B2 expression. Electron microscopy showed a marked loss of organelles essential for steroidogenesis. These findings suggest that osilodrostat exerts biochemical suppression of both cortisol and aldosterone secretion and modulates the morphology and function of the adrenocortical adenoma tissue.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Kobe University Hospital, Kobe, Hyogo 650-0017, Japan.
- Department of Diabetes and Endocrinology, Akashi Medical Center, Akashi 674-0043, Japan.
- Department of Diagnostic Pathology, Izumi City General Hospital, Izumi 594-0073, Japan.
- Department of Endocrinology and Diabetes, Izumi City General Hospital, Izumi 594-0073, Japan.
- Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi 983-8512, Japan.
ORCID-Profile: Maki Kanzawa
Förderung
- Japan Society for the Promotion of Science
- Health, Labour and Welfare Policy Research
Zitieren
APA
Kanzawa, M., Maeda, T., Ohta, Y., Ohno, Y., Nakamura, Y., & Chihara, K. (2026). Histopathological evidence of osilodrostat-induced regression of a cortisol-producing adrenocortical adenoma. JCEM Case Reports, 4(6). https://doi.org/10.1210/jcemcr/luag093
Vancouver
Kanzawa M, Maeda T, Ohta Y, Ohno Y, Nakamura Y, Chihara K. Histopathological evidence of osilodrostat-induced regression of a cortisol-producing adrenocortical adenoma. JCEM Case Reports. 2026;4(6). doi:10.1210/jcemcr/luag093
BibTeX
@article{Kanzawa2026,
author = {Kanzawa, Maki and Maeda, Takeshi and Ohta, Yoshio and Ohno, Yasuhiro and Nakamura, Yasuhiro and Chihara, Kazuo},
title = {Histopathological evidence of osilodrostat-induced regression of a cortisol-producing adrenocortical adenoma},
journal = {JCEM Case Reports},
year = {2026},
volume = {4},
number = {6},
doi = {10.1210/jcemcr/luag093}
}
EUVIMED